West Pharmaceutical Services Common Stock Net 2010-2024 | WST

West Pharmaceutical Services common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
  • West Pharmaceutical Services common stock net for the quarter ending September 30, 2024 was $0.019B, a 0% increase year-over-year.
  • West Pharmaceutical Services common stock net for 2023 was $0.019B, a 0% decline from 2022.
  • West Pharmaceutical Services common stock net for 2022 was $0.019B, a 0% decline from 2021.
  • West Pharmaceutical Services common stock net for 2021 was $0.019B, a 0% decline from 2020.
West Pharmaceutical Services Annual Common Stock Net
(Millions of US $)
2023 $19
2022 $19
2021 $19
2020 $19
2019 $19
2018 $19
2017 $19
2016 $18
2015 $18
2014 $18
2013 $18
2012 $17
2011 $9
2010 $9
2009 $9
West Pharmaceutical Services Quarterly Common Stock Net
(Millions of US $)
2024-09-30 $19
2024-06-30 $19
2024-03-31 $19
2023-12-31 $19
2023-09-30 $19
2023-06-30 $19
2023-03-31 $19
2022-12-31 $19
2022-09-30 $19
2022-06-30 $19
2022-03-31 $19
2021-12-31 $19
2021-09-30 $19
2021-06-30 $19
2021-03-31 $19
2020-12-31 $19
2020-09-30 $19
2020-06-30 $19
2020-03-31 $19
2019-12-31 $19
2019-09-30 $19
2019-06-30 $19
2019-03-31 $19
2018-12-31 $19
2018-09-30 $19
2018-06-30 $19
2018-03-31 $19
2017-12-31 $19
2017-09-30 $19
2017-06-30 $19
2017-03-31 $19
2016-12-31 $18
2016-09-30 $18
2016-06-30 $18
2016-03-31 $18
2015-12-31 $18
2015-09-30 $18
2015-06-30 $18
2015-03-31 $18
2014-12-31 $18
2014-09-30 $18
2014-06-30 $18
2014-03-31 $18
2013-12-31 $18
2013-09-30 $18
2013-06-30 $9
2013-03-31 $9
2012-12-31 $17
2012-09-30 $9
2012-06-30 $9
2012-03-31 $9
2011-12-31 $9
2011-09-30 $9
2011-06-30 $9
2011-03-31 $9
2010-12-31 $9
2010-09-30 $9
2010-06-30 $9
2010-03-31 $9
2009-12-31 $9
2009-09-30 $9
2009-06-30 $9
2009-03-31 $9
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49